Abbasi, B. et al. The effect of magnesium supplementation on primary insomnia in the elderly: a double-blind, placebo-controlled clinical trial. J. Res. Med. Sci. 17, 1161–1169 (2012).

Mah, J. and Pitre, T. Oral magnesium supplementation for insomnia in older adults: a systematic review and meta-analysis. BMC Complement. Med. Ther. 21, 125 (2021).

Yamadera, W. et al. Glycine intake improves subjective sleep quality in human volunteers, correlating with polysomnographic changes. Sleep Biol. Rhythms 5, 126–131 (2007)

Bannai, M. et al. The effects of glycine on subjective daytime performance in healthy volunteers with partial sleep restriction. Front. Neurol. 3, 61 (2012).

Schuette, SA, Lashner, BA and Janghorbani, M. Bioavailability of magnesium diglycinate versus magnesium oxide in patients with ileal resection. JPEN J. Parenter. Enteral Nutr. 18, 430–435 (1994).

de Baaij, JHF, Hoenderop, JGJ and Bindels, RJM Magnesium in man: Implications for health and disease. Physiol. Rev. 95, 1–46 (2015).

Costello, RB et al. Call for reassessment of the upper tolerable intake level of supplemental magnesium for adults. Adv. Nutr. 14, 1013–1026 (2023).

This randomized, double-blind, placebo-controlled clinical trial will test whether a magnesium glycinate supplement (480 mg/day) taken for 12 weeks reduces blood pressure.

The aim of this study is to evaluate whether supplementation with 480 mg/day of magnesium glycinate for 12 weeks reduces blood pressure.